Viewing nowGlizanuq Tablet 100mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Macknulty Pharmaceutical Co., Ltd.

MFDS item code 202301940 · Approved 2023.06.26 · Insurance code 641503020
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be used alone or in combination with other medications. This helps effectively manage blood sugar and aids in diabetes treatment.
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function before and periodically during treatment with this medication is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.
This medication may rarely cause serious allergic reactions; if you experience sudden rash, difficulty breathing, or swelling of the face or neck within 3 months of taking it, immediately stop taking it and consult your doctor. Serious side effects have been reported, including pancreatitis, which is inflammation of the pancreas. If you experience symptoms such as abdominal pain, vomiting, or loss of appetite, immediately inform a healthcare professional. This medication should not be used in patients with type 1 diabetes or those with ketoacidosis. Patients allergic to this medication or its components should not take it. Patients with reduced kidney function may have slower excretion of this medication, so dose adjustment is necessary and should be taken under a doctor's direction. During treatment with this medication, cold symptoms, headaches, upper respiratory infections, etc., may occur. If symptoms are severe or persistent, consult your healthcare provider. When used in conjunction with other diabetes medications, the risk of hypoglycemia may increase, so blood sugar changes should be carefully monitored, and dose adjustment of other medications may be necessary. If severe joint pain or skin blisters arise, stop taking this medication immediately and inform your doctor. Women who are pregnant or breastfeeding should avoid using this medication, and safety in pediatric patients under the age of 18 has not been established. Elderly patients may be at increased risk for decreased kidney function; therefore, regular kidney function tests should be performed before and during treatment. In case of overdose, seek immediate medical attention for appropriate treatment; this medication can be partially removed through dialysis.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering and should be kept at room temperature, between 1 and 30 degrees Celsius. This ensures the medication's effectiveness and prevents degradation.
Orange, round, biconvex film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Macknulty Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.